It is known that increased TGFβ2 levels in glaucoma may be due to epigenetics (Bermudez et al., 2016), suggesting that it is the increased TGFβ signaling that occurs first leading to production of excess ECM and DAMPs, which would then activate TLR4 leading to a feedforward signaling loop. Here, TGFB2 is linked to glaucoma.